Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

ZEISS MICROSCOPY

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract, identified as RMS #1100 and linked to Line Item 19768, pertains to the procurement titled "ZEISS MICROSCOPY" under purchase request number 84251. It is a forecast type contract managed by the Centers for Disease Control and Prevention (CDC), aimed at acquiring microscopy-related equipment or services associated with ZEISS. The contract details such as solicitation number, NAICS code, and precise location for the performance of work are not specified, reflecting a preliminary or planning stage status. Key points of contact include Linda Hall, serving as the Program Point of Contact, and a contracting officer whose identity is yet to be determined, both reachable via the provided CDC email. The contract is posted publicly on the HHS Office of Small and Disadvantaged Business Utilization industry opportunity forecast platform, signaling an open forecasting window for interested suppliers. The agreement does not include any set-aside type, suggesting it is not specifically reserved for small, disadvantaged, or other designated business categories at this time.

General Info

CDC forecast contract RMS #1100 for ZEISS microscopy equipment; contacts include Linda Hall.

Agency

Centers for Disease Control and Prevention → Centers For Disease Control And Prevention

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyCenters for Disease Control and Prevention → Centers For Disease Control And Prevention
Contacts2 people available
OfficeN/A
Organization / Agency
Centers for Disease Control and Prevention → Centers For Disease Control And Prevention
Office AddressN/A
Contacts
To Be Determined To Be DeterminedContracting Officer

Full Description

Show more
RMS # 1100, linked to Line item 19768, DVD/VVPDB_NEW_AA27295_ZEISS MICROSCOPY, PR # 84251

Similar Contracts

NAICS: 334516
New
Federal
Long-Read RNA Sequencing Kits for CARD iNDI Brain Sample StudyThe National Institutes of Health, specifically the National Institute on Aging (NIA), has issued a Notice of Intent to Sole Source for the procurement of brand-name Oxford Nanopore long-read RNA sequencing consumables. This acquisition supports the Center for Alzheimer’s Disease and Related Dementias’ (CARD) induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI). The government plans to award a firm-fixed-price purchase order exclusively to Oxford Nanopore Technologies, Inc. for specific consumables including 171 PromethION Flow Cells and 114 units of the cDNA-PCR Sequencing Kit. These supplies are essential for conducting large-scale RNA sequencing on 600 postmortem human brain samples to advance research on Alzheimer’s, Parkinson’s, and brain aging by analyzing gene expression and isoform diversity. The consumables must meet stringent performance criteria: flow cells need to generate data with modal accuracy above 99% and be fully compatible with government-owned Oxford Nanopore PromethION 48 sequencers, while the sequencing kits must require minimal RNA input and accommodate six reactions each. Due to the proprietary nature of the Oxford Nanopore platform, compatible items from other manufacturers are not acceptable. The acquisition authority is based on regulations permitting a sole source award when only one responsible source exists, under 41 U.S.C. 3304(a)(1) and FAR 6.302-1. Interested parties other than Oxford Nanopore may submit capability statements proving their ability to meet all specified requirements by June 23, 2026. Submissions must demonstrate equivalency or authorized distribution and clear compatibility with the existing sequencing equipment. The government will review responses to decide whether to proceed with sole sourcing or consider competitive procurement, retaining full discretion in this decision.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 12 days
View Details